Skip to main content

Table 2 Grade I/II and grade III/IV toxicity during 6 cycles of TAC in both groups

From: The effects of short-term fasting on tolerance to (neo) adjuvant chemotherapy in HER2-negative breast cancer patients: a randomized pilot study

  Grade I/II
  STF Non-STF
Fatigue 5 (71 %) 6 (100 %)
Infection 3 (43 %) 1 (17 %)
Mucositis 4 (57 %) 4 (67 %)
Neuropathy 5 (71 %) 3 (50 %)
Diarrhea 5 (71 %) 2 (33 %)
Dizziness 3 (43 %) 3 (50 %)
Nausea 7 (100 %) 4 (67 %)
Eye complaints 4 (57 %) 2 (33 %)
Constipation 4 (57 %) 2 (33 %)
  Grade III/IV
Total 6 3
Neutropenic fever 2 (29 %) 2 (33 %)
Fatigue 2 (29 %) 0 (0 %)
Infection 2 (29 %) 1 (17 %)
  1. All side effects were scored according CTCAE4.03. Each side effect was scored maximal once per patient during the course (the highest grade of occurrence was scored)
  2. STF short-term fasting